The role of upper airway pathology as a co-morbidity in severe asthma
- 15 September 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 11 (11) , 855-865
Abstract
Introduction: Severe asthma is a complex heterogeneous disease that is refractory to standard treatment and is complicated by multiple co-morbidities and risk factors. Several co-morbidities may contribute to worsen asthma control and complicate diagnostic and therapeutic management of severe asthmatic patients. Areas covered: A prevalent cluster of chronic upper airway co-morbid diseases is recognized in severe asthma. Evaluation for these disorders should always be considered in clinical practice. The aim of this review is to provide an updated overview of the prevalence, the pathogenetic mechanisms, the clinical impact and the therapeutic options for upper airway pathology in severe asthma, focusing on chronic rhinosinusitis and allergic rhinitis. Expert commentary: In the context of severe asthma, the clinical significance of upper airway co-morbidities is based on mutual interactions complicating diagnosis and management. A better analysis and understanding of phenotypes and endotypes of both upper and lower airway diseases are crucial to further develop targeted treatment.Keywords
This publication has 92 references indexed in Scilit:
- Severe adult-onset asthma: A distinct phenotypeJournal of Allergy and Clinical Immunology, 2013
- The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesisAllergologia et Immunopathologia, 2013
- Association between Severity of Asthma and Degree of Chronic RhinosinusitisAmerican Journal of Rhinology & Allergy, 2011
- IgE Influences the Number and Function of Mature Mast Cells, but Not Progenitor Recruitment in Allergic Pulmonary InflammationThe Journal of Immunology, 2009
- Blood and Sputum Eosinophil Levels in Asthma and Their Relationship to Sinus Computed Tomographic FindingsMayo Clinic Proceedings, 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic RhinitisPharmacoEconomics, 2007
- Survey on the impact of comorbid allergic rhinitis in patients with asthmaBMC Pulmonary Medicine, 2006
- Risk factors of frequent exacerbations in difficult-to-treat asthmaEuropean Respiratory Journal, 2005
- Allergic rhinitisJournal of Allergy and Clinical Immunology, 2004